Sr Therapeutic Specialist, Oncology - Albuquerque
Gilead SciencesSalary not specified
- Full Time
- Senior (5 to 8 years)
Bristol-Myers Squibb
Senior Therapeutic Area Specialist, Cardiovascular Specialty, Pensacola, FL
Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, Medical ScienceIndustries
Requirements
Candidates should possess a Bachelor’s degree in a scientific field, such as Biology, Pharmacology, or a related discipline, and have a minimum of 5 years of experience as a Therapeutic Area Specialist, preferably within the Cardiovascular specialty. Strong knowledge of cardiovascular disease, pharmacology, and clinical trial data is essential, along with demonstrated ability to build and maintain relationships with healthcare professionals.
Responsibilities
The Senior Therapeutic Area Specialist will drive demand for BMS medicines within their assigned territory, engaging with healthcare providers to articulate the clinical and scientific rationale for their use in appropriate patients. They will create and implement territory and account plans, proactively utilize tools like CE^3 to inform call plans, and provide feedback to ensure a high level of customer experience. The role also involves promoting approved indications of BMS products, maintaining scientific expertise, and collaborating with other BMS functions to deliver optimal results while exemplifying company values.
Skills
Cardiovascular disease
Pharmacology
Clinical trial data
Healthcare professionals
CE^3
Territory planning
Account planning
Customer experience
Bristol-Myers Squibb
Develops and delivers biopharmaceutical medicines
About Bristol-Myers Squibb
Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.
Key Metrics
New York City, New YorkHeadquarters
1887Year Founded
$33,706.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees